Protein Kinase C in Cancer Signaling and Therapy (Record no. 110823)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04550nam a22004575i 4500 |
001 - CONTROL NUMBER | |
control field | 978-1-60761-543-9 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20140220084513.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 100623s2010 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781607615439 |
-- | 978-1-60761-543-9 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/978-1-60761-543-9 |
Source of number or code | doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC261-271 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MJCL |
Source | bicssc |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED062000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 614.5999 |
Edition number | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kazanietz, Marcelo G. |
Relator term | editor. |
245 10 - TITLE STATEMENT | |
Title | Protein Kinase C in Cancer Signaling and Therapy |
Medium | [electronic resource] / |
Statement of responsibility, etc | edited by Marcelo G. Kazanietz. |
264 #1 - | |
-- | Totowa, NJ : |
-- | Humana Press : |
-- | Imprint: Humana Press, |
-- | 2010. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | XIV, 494p. 37 illus., 11 illus. in color. |
Other physical details | online resource. |
336 ## - | |
-- | text |
-- | txt |
-- | rdacontent |
337 ## - | |
-- | computer |
-- | c |
-- | rdamedia |
338 ## - | |
-- | online resource |
-- | cr |
-- | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
490 1# - SERIES STATEMENT | |
Series statement | Current Cancer Research |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Regulation of PKC Isozyme Function: From Genes to Biochemistry -- Protein Kinase C in Cancer Signaling and Therapy: Introduction and Historical Perspective -- Regulation of Conventional and Novel Protein Kinase C Isozymes by Phosphorylation and Lipids -- Phorbol Esters and Diacylglycerol: The PKC Activators -- Diacylglycerol Signaling: The C1 Domain, Generation of DAG, and Termination of Signals -- Regulation of PKC by Protein–Protein Interactions in Cancer -- PKC Isozymes in the Control of Cell Function -- Introduction: PKC Isozymes in the Control of Cell Function -- Regulation and Function of Protein Kinase D Signaling -- PKC and Control of the Cell Cycle -- PKC and the Control of Apoptosis -- Atypical PKCs, NF-?B, and Inflammation -- PKC Isozymes in Cancer -- Introduction: PKC and Cancer -- Protein Kinase C, p53, and DNA Damage -- PKCs as Mediators of the Hedgehog and Wnt Signaling Pathways -- PKC–PKD Interplay in Cancer -- Transgenic Mouse Models to Investigate Functional Specificity of Protein Kinase C Isoforms in the Development of Squamous Cell Carcinoma, a Nonmelanoma Human Skin Cancer -- PKC Isozymes and Skin Cancer -- PKC and Breast Cancer -- PKC and Prostate Cancer -- Protein Kinase C and Lung Cancer -- PKC Isozymes as Targets for Cancer Therapy -- PKC and Resistance to Chemotherapeutic Agents -- PKC? as a Target for Chemotherapeutic Drugs -- Atypical PKCs as Targets for Cancer Therapy. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Protein kinase C (PKC), a family of serine-threonine kinases, rocketed to the forefront of the cancer research field in the early 1980’s with its identification as an effector of phorbol esters, natural products with tumor-promoting activity. Phorbol esters had long been of interest to the cancer research field due to early studies in the mouse skin carcinogenesis model, which showed that prolonged topical application of phorbol esters promoted the formation of skin tumors on mice previously treated with mutagenic agents. Research in the last years has established key roles for PKC isozymes in the control of cell proliferation, migration, adhesion, and malignant transformation. In addition, there is a large body of evidence linking PKC to invasion and cancer cell metastasis. It is now well established that the expression of PKC isozymes is altered in various types of cancers. More importantly, small molecule inhibitors have been developed with significant anti-cancer activity. The relevance of PKC isozymes in cancer signaling is therefore remarkable. Protein Kinase C in Cancer Signaling and Therapy is composed of twenty-three chapters written by leading experts in the field. The book is divided into four sections: Regulation of PKC isozyme function: from genes to biochemistry, PKC isozymes in the control of cell function, PKC isozymes in cancer, and PKC isozymes as targets for cancer therapy. Each section of Protein Kinase C in Cancer Signaling and Therapy begins with an introduction by an established professional in the field of Protein kinase C, followed by chapters that elucidate the importance of PKC in current cancer research. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Oncology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Toxicology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Biomedicine. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Cancer Research. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacology/Toxicology. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY | |
Title | Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Printed edition: |
International Standard Book Number | 9781607615422 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Current Cancer Research |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-60761-543-9 |
912 ## - | |
-- | ZDB-2-SME |
No items available.